Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 14  •  04:00PM ET
27.13
Dollar change
+0.17
Percentage change
0.64
%
CategoryUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y3.61% Total Holdings70 Perf Week6.37%
SponsorFidelity ETF Type Tagsequity Return% 3Y- AUM60.51M Perf Month4.18%
Fund Family Bond Type Tagstechnology Return% 5Y- NAV/sh Perf Quarter11.61%
Index- Average Maturity Tagsmedical Return% 10Y 52W High27.41 -1.02% Perf Half Y15.61%
Index Weighting Commodity Type Tagsdisruptive Return% SI 52W Low20.69 31.13% Perf YTD10.01%
Active/Passive Quant Type Tagsinnovation Flows% 1M0.00% Volatility1.41% 1.00% Perf Year3.61%
Dividend TTM0.11 (0.41%) ESG Type Tags- Flows% 3M0.00% ATR (14)0.38 Perf 3Y-
Dividend Ex-DateDec 20, 2024 Dividend Type Sector/Theme Flows% YTD4.07% RSI (14)63.48 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta0.97 Perf 10Y-
Expense0.50% Growth/Value SMA202.57% Flows% 3Y Rel Volume1.97 Prev Close26.96
Inverse/Leveraged Market Cap SMA505.82% Flows% 5Y Avg Volume4.44K Price27.13
IPOJun 12, 2023 Option/ShortNo / Yes SMA20011.09% Trades Volume8,743 Change0.64%
Fidelity Disruptive Medicine ETF seeks long-term growth of capital. The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.